Haviland Kate - Insider Non-Derivative Transactions at Blueprint Medicines Corp (BPMC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 17, 2025, Haviland Kate's relationship to Blueprint Medicines Corp (BPMC) is Director,Officer (Chief Executive Officer), and currently has 295,139 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BPMC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Haviland Kate - Insider Non-Derivative Transactions of BPMC Common Stock

Haviland Kate - Insider Non-Derivative Transactions at BPMC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 18, 2025	U -- (Common Stock)	70729	0	0
Jul 18, 2025	Disposition -- (Common Stock)	224410	0	70729
Jul 18, 2025	Acquisition -- (Common Stock)	129210	0	295139
Apr 2, 2025	Sell -- (Common Stock)	100	88.59	165929
Apr 2, 2025	Sell -- (Common Stock)	1200	87.34	166029
Apr 2, 2025	Sell -- (Common Stock)	598	86.14	167229
Apr 2, 2025	Sell -- (Common Stock)	600	85.47	167827
Mar 6, 2025	Sell -- (Common Stock)	16151	88.8	168427
Mar 2, 2025	Acquisition -- (Common Stock)	35200	0	184578
Jan 22, 2025	Sell -- (Common Stock)	1446	110.24	149378
Nov 30, 2024	Sell -- (Common Stock)	207	97.76	150824
Nov 30, 2024	Sell -- (Common Stock)	1746	96.74	151031
Nov 30, 2024	Sell -- (Common Stock)	400	95.4	152777
Mar 8, 2024	Sell -- (Common Stock)	12464	90.69	153177
Mar 2, 2024	Acquisition -- (Common Stock)	40000	0	165641
Mar 7, 2023	Sell -- (Common Stock)	212	44.65	125641
Mar 7, 2023	Sell -- (Common Stock)	6428	45.72	125853
Mar 2, 2023	Acquisition -- (Common Stock)	40000	0	132281